Impact of international autoimmune hepatitis group scoring system in definition of autoimmune hepatitis: An Italian experience

Digestive Diseases and Sciences

Volumn 41, Issue 1, 1996, Pages 166-171

  Bianchi, Francesco B ^a,b   Cassani, Fabio ^a   Lenzi, Marco ^a   Ballardini, Giorgio ^a   Muratori, Luigi ^a   Giostra, Fabrizio ^a   Zauli, Daniela ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Autoantibodies; Autoimmune hepatitis; Hepatitis C virus

Indexed keywords

AUTOANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOIMMUNE HEPATITIS; CHILD; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEPATITIS C; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SCORING SYSTEM; VIREMIA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, ANTINUCLEAR; AUTOANTIBODIES; AUTOIMMUNE DISEASES; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; FEMALE; HEPATITIS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; MALE; MIDDLE AGED; MUSCLE, SMOOTH; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES;

EID: 0030063459     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02208600     Document Type: Article

References (22)

1. Czaja AJ: Diagnosis, prognosis, and treatment of classical autoimmune chronic active hepatitis. In Autoimmune Liver Diseases. EL Krawitt, RH Wiesner (eds). New York, Raven, 1991, pp 143-166
2. Lenzi M, Ballardini G, Fusconi M, Cassani F, Selleri L, Volta U. Zauli D, Blanchi FB: Type 2 autoimmune hepatitis and hepatitis C virus infection. Lancet 335:258-259, 1990
3. Garson JA, Lenzi M, Ring C, Cassani F, Ballardini G, Briggs M, Tedder RS, Bianchi FB: Hepatitis C viraemia in adults with type 2 autoimmune hepatitis. J Med Virol 34:223-226, 1991
4. Cassani F, Muratori L, Manotti P, Lenzi M, Fusconi M, Ballardini G, Selleri L, Volta U, Zauli D, Miniero R, Bianchi FB: Serum autoantibodies and the diagnosis of type-1 autoimmune hepatitis in Italy: a reappraisal at the light of hepatitis C virus infection. Gut 33:1260-1263, 1993
5. Lenzi M, Johnson PJ, McFarlane IG, Ballardini G, Smith HM, McFarlane BM, Bridger C, Vergani D, Bianchi FB, Williams R: Antibodies to hepatitis C virus in autoimmune liver disease: evidence for geographical heterogeneity. Lancet 338:277-280, 1991
6. Johnson PJ, McFarlane IG (convenors on behalf of the panel): Meeting report: International Autoimmune Hepatitis Group. Hepatology 18:998-1005, 1993
7. Anon: Terminology of chronic hepatitis, hepatic allograft rejection, and nodular lesions of the liver: Summary of recommendations developed by an International Working Party, supported by the World Congress of Gastroenterology, Los Angeles 1994. Am J Gastroenterol 89:177-181, 1994
8. Muratori L, Cataleta M, Muratori P, Manotti P, Lenzi M, Cassani F, Bianchi FB: Detection of anti-liver cytosol antibody type 1 (anti-LC1) by immunodiffusion, counterimmunoelectrophoresis and immunoblotting: Comparison of different techniques. J Immunol Methods 1995 (in press)
9. Cassani F, Bianchi FB, Lenzi M, Volta U, Pisi E: Immunomorphological characterization of antinuclear antibodies in chronic liver disease. J Clin Pathol 38:801-805, 1985
10. Fusconi M, Cassani F, Zauli D, Lenzi M, Ballardini G, Volta U, Bianchi FB: Anti-actin antibodies: A new test for an old problem. J Immunol Methods 130:1-8, 1990
11. Lunel F: Hepatitis C virus and autoimmunity: Fortuitous association or reality? Gastroenterology 107:1550-1555, 1994 (editorial)
12. Muratori L, Giostra F, Cataleta M, Francesconi R, Ballardini G, Cassani F, Lenzi M, Bianchi FB: Testing for hepatitis C virus sequences in peripheral blood mononuclear cells of patients with chronic hepatitis C in the absence of serum hepatitis C virus RNA. Liver 14:124-128, 1994
13. Lenzi M, Manotti P, Muratori L, Cataleta M, Ballardini G, Cassani F, Bianchi FB: Liver cytosolic 1 antigen-antibody system in type 2 autoimmune hepatitis and hepatitis C virus infection. Gut 36:749-754, 1995
14. Roarty TP, Gaffey MJ, Featherson PL, Caldwell SH, Dickson RC: Application of the International Autoimmune Hepatitis Group scoring system to chronic hepatitis C patients. Gastroenterology 106 (suppl 4):A969, 1994
15. Shindo M, Di Bisceglie AM, Hoofnagle JH: Acute exacerbation of liver disease during interferon alfa therapy for chronic hepatitis. Gastroenterology 102:1406-1408, 1992
16. Papo T, Marcellin P, Bernuau J, Durand F, Poynard T, Benhamou JP: Autoimmune chronic hepatitis exacerbated by alpha interferon. Ann Intern Med 116:51-53, 1992
17. Muratori L, Lenzi M, Cataleta M, Giostra F, Cassani F, Ballardini G, Zauli D, Bianchi FB: Interferon therapy in liver/ kidney microsomal antibody type 1-positive patients with chronic hepatitis C. J Hepatol 21:199-203, 1994
18. Zeniya M, Aizawa Y, Watanabe F, Kawabe T, Hara M, Sakaguchi M, Toda G: HCV-marker-positive autoimmune-type chronic active hepatitis: A possible relation between HCV infection and liver autoreactivity. Liver 14:206-212, 1994
19. Michel G, Ritter A, Gerken G, Meyer zum Buschenfelde K-H, Decker R, Manns MP: Anti-GOR and hepatitis C virus in autoimmune liver diseases. Lancet 339:267-269, 1992
20. Lunel F, Abuaf N, Frangeul L, Grippon P, Perrin M, Le Coz Y, Valla D, Borotto E, Yamamoto AM, Huraux JM, Opolon P, Homberg JC: Liver/kidney microsome antibody type 1 and hepatitis C virus infection. Hepatology 16:630-636, 1992
21. Manns MP, Griffin KJ, Sullivan KF, Johnson EF: LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 monooxigenase. J Clin Invest 88:1370-1378, 1991
22. Muratori L, Lenzi M, Ma Y, Cataleta M, Mieli-Vergani G, Vergani D. Bianchi FB: Heterogeneity of liver/kidney microsomal antibody type 1 in autoimmune hepatitis and hepatitis C virus-related liver disease. Gut 37:406-412, 1995